Combined antiviral-antimediator treatment for the common cold.
about
Iota-Carrageenan is a potent inhibitor of rhinovirus infectionAcetaminophen (paracetamol) for the common cold in adultsOral antihistamine-decongestant-analgesic combinations for the common coldAntihistamines for the common coldAntihistamines for the common coldPotential benefits of ibuprofen in the treatment of viral respiratory infections.In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteersEfficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.Health-related quality of life of adults with upper respiratory tract infections.Current and future therapeutic approaches to the common cold.Achievements and challenges in antiviral drug discovery.New horizons: Current and potential future self-treatments for acute upper respiratory tract conditions.The common cold: potential for future prevention or cure.The regulation of rhinovirus infection in vitro by IL-8, HuIFN-alpha, and TNF-alpha.Effects of upper respiratory tract illnesses, ibuprofen and caffeine on reaction time and alertness.
P2860
Q21245131-253A8B38-B9F0-43CD-9452-377E53CC3801Q24201410-A02DFF57-755A-4ADA-AAA0-2E6F0DD18F6FQ24203688-7FB6DE9D-DAFE-4082-95A2-16EC7B0C9AEBQ24240755-EF686B95-5843-4740-99EA-F4AD5DCDBAE3Q24247974-F5A4A947-6B94-439E-993E-AA0348AF3F5FQ30433148-F47D2D4E-C76E-4DBC-8E33-B23487DF3B3EQ30448335-10D9AA50-7A45-410E-8E7E-237C9C0306AEQ30448643-9F8DD055-DD19-45A2-856F-BDF104FAC5B4Q30451184-7AECA0DA-9E60-46ED-9A92-A26CC2FB8576Q34656522-97D45975-7132-439B-B6AF-C95B4D3543A9Q34742374-F2A3D23B-FB06-4E77-AE3F-E306F1DA45C1Q35917302-A181FC6B-19B1-4EF6-AFE4-E0286DB82DD8Q36186792-286A7838-6CB0-48DF-96A2-F0C43DA30FEAQ38079920-3E9EEEE5-A346-4C53-976B-1ABA514A8CC0Q38177756-50B2DBE0-5E71-40D4-8743-37E3D1AD8C12Q40553962-AA3FC82F-F83B-497D-B86E-5064F8132BC0Q44740732-3336F079-3855-4BE2-964E-BEC0C0837521
P2860
Combined antiviral-antimediator treatment for the common cold.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Combined antiviral-antimediator treatment for the common cold.
@ast
Combined antiviral-antimediator treatment for the common cold.
@en
type
label
Combined antiviral-antimediator treatment for the common cold.
@ast
Combined antiviral-antimediator treatment for the common cold.
@en
prefLabel
Combined antiviral-antimediator treatment for the common cold.
@ast
Combined antiviral-antimediator treatment for the common cold.
@en
P2093
P356
P1476
Combined antiviral-antimediator treatment for the common cold.
@en
P2093
Birgit Winther
J Owen Hendley
Jack M Gwaltney
James T Patrie
P304
P356
10.1086/341455
P407
P577
2002-07-03T00:00:00Z